期刊
CELL
卷 148, 期 6, 页码 1242-1257出版社
CELL PRESS
DOI: 10.1016/j.cell.2012.03.001
关键词
-
资金
- NHLBI/NIH
- Foundation Leducq
- Massachusetts General Hospital
- Pfizer
- Merck
- Alnylam
- Shire Therapeutics
- California Institute for Regenerative Medicine
- Younger Family Foundation
- Roddenberry Foundation
- Whittier Foundation
Cardiovascular disease encompasses a range of conditions extending from myocardial infarction to congenital heart disease, most of which are heritable. Enormous effort has been invested in understanding the genes and specific DNA sequence variants that are responsible for this heritability. Here, we review the lessons learned for monogenic and common, complex forms of cardiovascular disease. We also discuss key challenges that remain for gene discovery and for moving from genomic localization to mechanistic insights, with an emphasis on the impact of next-generation sequencing and the use of pluripotent human cells to understand the mechanism by which genetic variation contributes to disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据